Long‐term comparison of high‐ and low‐dose oral immunotherapy in children with anaphylactic cow's milk allergy
Pediatric Allergy and Immunology · 2025-02 · 36 (2)
DOI: 10.1111/pai.70033 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Pediatric Allergy and Immunology, online erschienen am 01.02.2025. Verfasst von Yu Ito und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Center for Allergy and Rheumatology, NHO Sagamihara National Hospital, Sagamihara, Kanagawa, Japan. Hauptthemen laut MEDLINE: Milk Hypersensitivity, Anaphylaxis, Desensitization, Immunologic, Allergens. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Long‐term evidence on maintenance doses of oral immunotherapy (OIT) for anaphylactic cow's milk allergy is insufficient.
Methods
We retrospectively compared the three‐year safety, efficacy, and adherence between OIT with a maintenance dose of 200 mL of cow's milk (HOIT, 2009–2013) and 3 mL of cow's milk (LOIT, 2013–2019). Patients aged 6–18 years with a history of anaphylaxis reacting to ≤3 mL of cow's milk during oral food challenge (OFC) were included. Adverse symptoms, OFC negative rate after 2 weeks of avoidance, dropout rate, and immunological changes were compared.
Results
The median ages in the HOIT ( n = 78) and LOIT ( n = 99) groups were 8.1 and 7.8 years, with milk‐specific IgE levels of 56.5 and 49.2 kUA/L, respectively. The percentages of doses triggering symptoms were 20.88%, 13.73%, and 7.31% in the HOIT group and 11.81%, 8.15%, and 6.30% in the LOIT group during years 1, 2, and 3, respectively. After 3 years, 29% of patients in the HOIT group passed the OFC with 200 mL, and 47%, 18%, and 5% of patients in the LOIT group passed the OFC with ≥25 mL, ≥50 mL, and 100 mL of cow's milk, respectively. After 3 years, the dropout rates were 24% and 11% in the HOIT and LOIT groups and milk‐specific IgE levels decreased by 88% and 78% in the HOIT and LOIT groups, respectively.
Conclusion
HOIT enables higher dose consumptions. LOIT might be safer and have higher adherence in patients with anaphylactic cow's milk allergy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Research Center for Allergy and Rheumatology, NHO Sagamihara National Hospital, Sagamihara, Kanagawa, Japan.
- Course of Allergy and Clinical Immunology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.
- Department of Pediatrics, Jikei University School of Medicine, Tokyo, Japan.
ORCID-Profile: Yu Ito, Ken-Ichi Nagakura, Sakura Sato, Motohiro Ebisawa, Noriyuki Yanagida
Zitieren
APA
Ito, Y., Nagakura, K. I., Sato, S., Ebisawa, M., & Yanagida, N. (2025). Long‐term comparison of high‐ and low‐dose oral immunotherapy in children with anaphylactic cow's milk allergy. Pediatric Allergy and Immunology, 36(2). https://doi.org/10.1111/pai.70033
Vancouver
Ito Y, Nagakura KI, Sato S, Ebisawa M, Yanagida N. Long‐term comparison of high‐ and low‐dose oral immunotherapy in children with anaphylactic cow's milk allergy. Pediatric Allergy and Immunology. 2025;36(2). doi:10.1111/pai.70033
BibTeX
@article{Ito2025,
author = {Ito, Yu and Nagakura, Ken-Ichi and Sato, Sakura and Ebisawa, Motohiro and Yanagida, Noriyuki},
title = {Long‐term comparison of high‐ and low‐dose oral immunotherapy in children with anaphylactic cow's milk allergy},
journal = {Pediatric Allergy and Immunology},
year = {2025},
volume = {36},
number = {2},
doi = {10.1111/pai.70033}
}
EUVIMED